Position in BLTE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$78,842,282
+$65,394,925 QoQ
Shares Held
494,495
+488.2% QoQ
Ownership
1.23%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BLTE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Holocene Advisors, LP holds $1,357,789,985 across 26 Biotechnology names. BLTE ranks #8 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
2,468,644 | $240,075,629 | |
| 2 | TERN |
Terns Pharmaceuticals, Inc.
|
4,115,828 | $216,986,452 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
733,905 | $138,744,740 | |
| 4 | SRRK |
Scholar Rock Holding Corp
|
1,890,927 | $92,957,971 | |
| 5 | XENE |
Xenon Pharmaceuticals Inc.
|
1,518,686 | $88,311,590 | |
| 6 | COGT |
Cogent Biosciences, Inc.
|
2,250,196 | $86,610,044 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
3,932,603 | $82,270,054 | |
| 8 | BLTE |
Belite Bio, Inc
This page
|
494,495 | $78,842,282 |
All Filings in BLTE
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $78,842,282 | 494,495 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $13,447,357 | 84,067 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||